Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Sort ascending Bone Marrow Disease
Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Annals of Oncology: Official Journal of the European Society for Medical Oncology Myelodysplastic Syndromes (MDS)
Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes Annals of internal medicine Myelodysplastic Syndromes (MDS)
Health-related quality of life and symptom-specific functional impairment among patients treated with parenterally administered complement inhibitors for paroxysmal nocturnal hemoglobinuria Annals of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia Annals of Hematology Aplastic Anemia
Patient-reported outcomes in patients with paroxysmal nocturnal hemoglobinuria treated with crovalimab and approved C5 inhibitors in the phase III COMMODORE 2 and 1 studies Annals of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion Annals of Hematology Myelodysplastic Syndromes (MDS)
Baseline Clinical Characteristics and Disease Burden in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): Updated Analysis From the International PNH Registry Annals of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria Annals of Hematology Paroxysmal Nocturnal Hemoglobinuria (PNH)
Evolving therapies for lower-risk myelodysplastic syndromes Annals of Hematology Myelodysplastic Syndromes (MDS)
The effect of hetrombopag combined with conventional treatment on immune function and quality of life in patients with severe aplastic anemia Annals of Hematology Aplastic Anemia

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.